www.nbcnews.com Open in urlscan Pro
104.111.215.198  Public Scan

URL: https://www.nbcnews.com/health/health-news/cdc-says-no-safety-problems-pfizer-moderna-vaccines-after-first-n1258367
Submission: On October 19 via api from QA — Scanned from DE

Form analysis 3 forms found in the DOM

GET https://www.nbcnews.com/search

<form action="https://www.nbcnews.com/search" method="GET" class="search-form js-search-form"><label class="search-label" for="q" id="search_label">Search</label>
  <div class="search-inner"><input type="search" class="search-input js-search-input" aria-labelledby="search_label" id="q" name="q" placeholder="Search NBC News"><button class="search-button"><span class="search-button-icon"><svg
          xmlns="http://www.w3.org/2000/svg" viewBox="0 0 20 20" fill="currentColor">
          <path fill-rule="evenodd" d="M13.773 11.649L20 17.876 17.876 20l-6.227-6.227a7.508 7.508 0 112.124-2.124zm-6.265.364a4.505 4.505 0 100-9.01 4.505 4.505 0 000 9.01z"></path>
        </svg></span></button></div>
</form>

GET https://www.nbcnews.com/search

<form action="https://www.nbcnews.com/search" method="GET" class="search-form js-search-form"><label class="search-label" for="q" id="search_label">Search</label>
  <div class="search-inner"><input type="search" class="search-input js-search-input" aria-labelledby="search_label" id="q" name="q" placeholder="Search NBC News"><button class="search-button"><span class="search-button-icon"><svg
          xmlns="http://www.w3.org/2000/svg" viewBox="0 0 20 20" fill="currentColor">
          <path fill-rule="evenodd" d="M13.773 11.649L20 17.876 17.876 20l-6.227-6.227a7.508 7.508 0 112.124-2.124zm-6.265.364a4.505 4.505 0 100-9.01 4.505 4.505 0 000 9.01z"></path>
        </svg></span></button></div>
</form>

<form class="nl-signup-input__form"><input class="nl-signup-input__input" name="emailAddress" placeholder="Enter your email" value=""><button class="animated-ghost-button animated-ghost-button--normal nl-signup-input__button"
    id="email-subscribe-button" type="button">Sign Up</button></form>

Text Content

IE 11 is not supported. For an optimal experience visit our site on another
browser.
SKIP TO CONTENT
Sponsored By

 * Southlake Podcast
 * U.S. News
 * Politics
 * Covid-19
 * World
 * Opinion
 * Business




CDC says no safety problems with Pfizer, Moderna Covid vaccines after first
month

 * Share this —
 * 
 * 
 * 
 * 
 * 

Search


Sections

 * CORONAVIRUS
 * U.S. News
 * Politics
 * World
 * Local
 * Business
 * Health
 * Investigations
 * Culture Matters
 * Science
 * Sports
 * Tech & Media
 * Decision 2020
 * Video Features
 * Photos
 * Weather
 * Select
 * Asian America
 * NBCBLK
 * NBC Latino
 * NBC OUT

TV

 * Today
 * MSNBC
 * Nightly News
 * Meet The Press
 * Dateline

Featured

 * NBC NEWS NOW
 * THINK
 * BETTER
 * NIGHTLY FILMS
 * STAY TUNED
 * SPECIAL FEATURES
 * NEWSLETTERS
 * PODCASTS

More from NBC

 * CNBC
 * NBC.COM
 * NBC LEARN
 * Peacock
 * Next Steps for Vets
 * Parent Toolkit
 * NBC Archives
 * Help

Follow NBC News

 * 
 * 
 * 

Search

 * Facebook
 * Twitter
 * Email
 * SMS
 * Print
 * Whatsapp
 * Reddit
 * Pocket
 * Flipboard
 * Pinterest
 * Linkedin

Manage ProfileEmail PreferencesSign Out



Coronavirus


CDC SAYS NO SAFETY PROBLEMS WITH PFIZER, MODERNA COVID VACCINES AFTER FIRST
MONTH

No deaths have been attributed to the vaccines, the data showed.

Feb. 19, 2021, 8:19 PM UTC / Source: Reuters
By Reuters

The two Covid-19 vaccines approved for use in the United States have reassuring
safety profiles with no concerning new issues found in data collected from the
first month of vaccinations, the Centers for Disease Control and Prevention said
on Friday.

After administration of 13.8 million doses of the Pfizer-BioNTech and Moderna
vaccines to the U.S. population, most reports indicated non-serious side effects
of the type that had been expected, such as headaches and fatigue. No deaths
have been attributed to the vaccines, the data showed.




The CDC collected data between Dec. 14, 2020 and Jan. 13, 2021 from both an
existing national surveillance system for adverse events and its own safety
monitoring system established for Covid-19 vaccines.



Full coverage of the coronavirus outbreak

During that time, 6,994 reports of adverse events after vaccination were
recorded in the national surveillance system with 90.8 percent of them
classified as non-serious and 9.2 percent as serious.


RECOMMENDED


Coronavirus


CORONAVIRUSAGE, UNDERLYING HEALTH CONDITION WERE 'DOUBLE BLOW' TO COLIN POWELL,
EXPERTS SAY


Coronavirus


CORONAVIRUSRUSSIA HIT BY LARGEST DAILY NUMBER OF NEW CORONAVIRUS INFECTIONS

Rare cases of anaphylaxis, a severe allergic reaction requiring medical
attention, were reported with both vaccines at a rate of 4.5 cases per million
doses administered, down from the agency's previously reported rate of 5 per
million doses administered. The rate of anaphylaxis linked to Covid shots is
similar to other vaccines, CDC director Dr. Rochelle Walensky said Friday during
the White House Covid-19 Response Team briefing.



"Healthcare providers and vaccine recipients can be reassured about the safety
of Pfizer and Moderna Covid-19 vaccines," the CDC said in its Morbidity and
Mortality Weekly Report.

A total of 113 deaths were reported, including from death certificates and
autopsy reports. No causal link between Covid-19 vaccination and fatalities was
found, according to the CDC report.

Get the Morning Rundown

Get a head start on the morning's top stories.

Sign Up
This site is protected by recaptcha Privacy Policy | Terms of Service

Reuters


 * About
 * Contact
 * Help
 * Careers
 * Ad Choices
 * Privacy policy
 * Do Not Sell My Personal Information
 * CA Notice
 * Terms of Service
 * NBC NEWS SITEMAP
 * Advertise

© 2021 NBC UNIVERSAL


WE AND OUR PARTNERS USE COOKIES ON THIS SITE TO IMPROVE OUR SERVICE, PERFORM
ANALYTICS, PERSONALIZE ADVERTISING, MEASURE ADVERTISING PERFORMANCE, AND
REMEMBER WEBSITE PREFERENCES. BY USING THE SITE, YOU CONSENT TO THESE COOKIES.
FOR MORE INFORMATION ON COOKIES INCLUDING HOW TO MANAGE YOUR CONSENT VISIT OUR
COOKIE POLICY.
CONTINUE